Analyst Expectations for Immunocore Hldgs's Future
Portfolio Pulse from Benzinga Insights
Immunocore Hldgs (NASDAQ:IMCR) has received mostly bullish ratings from analysts in the last quarter, with an average 12-month price target of $80.36, an increase of 1.88% over the past month. The ratings are based on predictions of the company's future earnings and revenue streams.
September 13, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunocore Hldgs has received mostly bullish ratings from analysts, indicating a positive outlook for the stock.
The bullish ratings and increased price target indicate analysts' positive outlook on Immunocore Hldgs, which could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100